Use of secukinumab in a pediatric patient leads to significant improvement in nail psoriasis and psoriatic arthritis

Use of secukinumab in a pediatric patient leads to significant improvement in nail psoriasis and psoriatic arthritis

Many pediatric psoriasis patients suffer from nail involvement and psoriatic arthritis. In adults, biologic agents have demonstrated success in treating refractory nail psoriasis and arthritis, but studies are limited in children. In this report, we present a pediatric patient with severe, recalcitr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric dermatology 2019-05, Vol.36 (3), p.384-385
Hauptverfasser: Wells, Leah Ellis, Evans, Tyler, Hilton, Rachael, Wine Lee, Lara, Ruth, Natasha
Format: Artikel
Sprache:eng
Schlagworte:
Antibodies, Monoclonal, Humanized - therapeutic use
Arthritis
Arthritis, Psoriatic - drug therapy
Child
Female
Humans
Monoclonal antibodies
Nail Diseases - drug therapy
Nail Diseases - etiology
Nail Diseases - pathology
nail disorders
Patients
Pediatrics
Psoriasis
Psoriatic arthritis
secukinumab
therapy‐systemic
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Many pediatric psoriasis patients suffer from nail involvement and psoriatic arthritis. In adults, biologic agents have demonstrated success in treating refractory nail psoriasis and arthritis, but studies are limited in children. In this report, we present a pediatric patient with severe, recalcitrant nail and joint psoriasis, successfully treated with secukinumab.
ISSN:0736-8046
1525-1470
DOI:10.1111/pde.13767